Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats

Pain

Volumn 105, Issue 1-2, 2003, Pages 109-114

  Shin, Sang Wook ^a,b   Sandner Kiesling, Andreas ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Cyclooxygenase; Ketorolac; Prostaglandins; Uterine cervical distension (UCD); Visceral pain

Indexed keywords

KETOROLAC; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG EFFICACY; DRUG INHIBITION; ELECTROMYOGRAPHY; EPIDURAL CATHETER; ESTROGEN THERAPY; HORMONE DEPENDENCE; INTERMETHOD COMPARISON; MEAN ARTERIAL PRESSURE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RECORDING; RECTUS ABDOMINIS MUSCLE; STIMULUS RESPONSE; UTERINE CERVIX DILATATION;

EID: 0141515740     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00172-6     Document Type: Article

References (26)

1. Buckley M.M.T., Brogden R.N. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 39:1990;86-109.
2. Eisenach J.C., Curry R., Hood D.D., Yaksh T.L., Phase I. safety assessment of IT ketorolac. Pain. 99:2002;599-604.
3. Ferreira S.H., Nakamura M., de Abreu Castro M.S. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandin. 16:1978;31-37.
4. Fillingim R.B., Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 24:2000;485-501.
5. Lauretti G.R., Reis M.P., Mattos A.L., Gomes J.M.A., Olivera A.P.M., Pereira N.L. Epidural nonsteroidal anti-inflammatory drugs for cancer pain. Anesth Analg. 86:1998;117-118.
6. Litvak K.M., McEvoy G.K. Kotorolac, an injectable nonnarcotic analgesic. Clin Pharm. 9:1990;921-935.
7. Ma W., Eisenach J.C. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 937:2002;94-99.
8. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1279.
9. Malmberg A.B., Yaksh T.L. Antinociceptive action of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 263:1992;136-146.
10. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 79:1993;270-281.
11. Malmberg A.B., Yaksh T.L. Cyclooxygenase inhibition and the spinal release of prostagladin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci. 15:1995;2768-2776.
12. Maves T.J., Pechman P.S., Meller S.T., Gebhart G.F. Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology. 80:1994;1094-1101.
13. Minami T., Uda R., Horiguchi S., Ito S., Hyodo M., Hayaishi O. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. Pain. 57:1994;217-223.
14. Myers K.G., Trotman I.F. Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. Postgrad Med J. 70:1994;359-362.
15. Parris W.C.V., Janicki P.K., Johnson B., Horn J.L. Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve injury of sciatic nerve in rat. Can J Anaesth. 43:1996;857-870.
16. Rooks W.H. 2nd, Maloney P.J., Shott L.D., Schuler M.E., Sevelius H., Strosberg A.M., Tanenbaum L., Tomolonis A.J., Wallach M.B., Waterbury D., Yee J.P. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res. 11:1985;479-492.
17. Saito Y., Kaneko M., Kirihara Y., Kosaka Y., Collins J.G. Intrathecal prostaglandin E1 produces a long-lasting allodynic state. Pain. 63:1995;303-311.
18. Sandner-Kiesling A., Pan H.L., Chen S.R., James R.L., Dehaven-Hudkins D.L., Dewan D.M., Eisenach J.C. Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats. Pain. 96:2002;13-22.
19. Sandner-Kiesling A., Eisenach J.C. Pharmacology of opioid inhibition to noxious uterine cervical distension. Anesthesiology. 97:2002;966-971.
20. Sandner-Kiesling A., Eisenach J.C. Estrogen reduces efficacy of μ- but not κ-opioid agonist inhibition in response to uterine cervical distension. Anesthesiology. 96:2002;375-379.
21. Shin S.W., Eisenach J.C. Intrathecal morphine reduces response to acute uterine cervical distension in an estrogen-independent manner. Anesthesiolgy. 2003;1. In submission.
22. Southall M.D., Michael R.L., Vasko M.R., Intrathecal N.S.A.I.D.S. attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain. 78:1998;39-48.
23. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 7:1976;1032-1036.
24. Yaksh T.L., Dirig D.M., Conway C.M., Svensson C., Luo Z.D., Isakson P.C. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of spinal cyclooxygenase-s (COX-2) but no COX-1. J Neurosci. 21:2001;5847-5853.
25. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 306:1983;686-688.
26. Woolf C.J., Shortland P., Sivilotti L.G. Sensitization of high mechanothreshold superficial dorsal horn and flexor motor neurons following chemosensitive primary afferent activation. Pain. 58:1994;141-155.